VivoSeq
Other

Laparoscopic

2

Pipeline Programs

10

Active Trials

5

Companies Involved

Laparoscopic is an early-stage landscape with 2 programs across 5 companies. The most active players are Acacia Pharma Ltd, Fresenius Kabi Oncology Ltd., Pacira Pharmaceuticals, Inc. 2 therapies are approved.

Pipeline Metrics

Competitive Density

31/100

Pipeline Velocity

19/100

Mech. Concentration

100/100

Completion Rate

84/100

Attrition Rate

10/100

Competitive Landscape

Bubble size = clinical trials

Approved
Phase 3
Phase 2
Phase 1
Preclinical

Programs by Phase

Preclinical
No programs
Phase 1
No programs
Phase 2
No programs
Phase 3
No programs

Trial Status

67

clinical trials

Completed36 · 54%
Unknown status14 · 21%
Recruiting8 · 12%
Terminated5 · 7%
Withdrawn2 · 3%
Not yet recruiting2 · 3%

Trial Activity

67 trials

QL Block in Laparoscopic Myomectomy
Recruiting··Phase 4·NCT05979493·80 enrolled
Opioid Use After Laparoscopic Salpingectomy
Recruiting·JJohns Hopkins University·Phase 4·NCT06434233·120 enrolled
Intrathecal Mg in Gynecologic Laparoscopic Surgeries.
Completed··Phase 2·NCT02671227·50 enrolled
Laparoscopic Tubal Patency Assessment
Completed··N/A·NCT01725477·30 enrolled
Page 1 of 5

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)